APA

Vincent T., Portales P., Baillat V., de Boever C. M., Le Moing V., Vidal M., Ducos J., Clot J., Reynes J. & Corbeau P. (20050412). T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonists. : Journal of acquired immune deficiency syndromes (1999).

Chicago

Vincent Thierry, Portales Pierre, Baillat Vincent, de Boever Corinne Merle, Le Moing Vincent, Vidal Michèle, Ducos Jacques, Clot Jacques, Reynes Jacques and Corbeau Pierre. 20050412. T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonists. : Journal of acquired immune deficiency syndromes (1999).

Harvard

Vincent T., Portales P., Baillat V., de Boever C. M., Le Moing V., Vidal M., Ducos J., Clot J., Reynes J. and Corbeau P. (20050412). T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonists. : Journal of acquired immune deficiency syndromes (1999).

MLA

Vincent Thierry, Portales Pierre, Baillat Vincent, de Boever Corinne Merle, Le Moing Vincent, Vidal Michèle, Ducos Jacques, Clot Jacques, Reynes Jacques and Corbeau Pierre. T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonists. : Journal of acquired immune deficiency syndromes (1999). 20050412.